These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

64 related items for PubMed ID: 16513101

  • 1. Unveiling molecular mechanisms of pneumococcal surface protein A interactions with antibodies and lactoferrin.
    Jedrzejas MJ.
    Clin Chim Acta; 2006 May; 367(1-2):1-10. PubMed ID: 16513101
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Combined effects of lactoferrin and lysozyme on Streptococcus pneumoniae killing.
    André GO, Politano WR, Mirza S, Converso TR, Ferraz LF, Leite LC, Darrieux M.
    Microb Pathog; 2015 Dec; 89():7-17. PubMed ID: 26298002
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Identification of pneumococcal surface protein A as a lactoferrin-binding protein of Streptococcus pneumoniae.
    Hammerschmidt S, Bethe G, Remane PH, Chhatwal GS.
    Infect Immun; 1999 Apr; 67(4):1683-7. PubMed ID: 10085004
    [Abstract] [Full Text] [Related]

  • 8. Production and characterization of the functional fragment of pneumococcal surface protein A.
    Jedrzejas MJ, Hollingshead SK, Lebowitz J, Chantalat L, Briles DE, Lamani E.
    Arch Biochem Biophys; 2000 Jan 01; 373(1):116-25. PubMed ID: 10620330
    [Abstract] [Full Text] [Related]

  • 9. The effects of differences in pspA alleles and capsular types on the resistance of Streptococcus pneumoniae to killing by apolactoferrin.
    Mirza S, Benjamin WH, Coan PA, Hwang SA, Winslett AK, Yother J, Hollingshead SK, Fujihashi K, Briles DE.
    Microb Pathog; 2016 Oct 01; 99():209-219. PubMed ID: 27569531
    [Abstract] [Full Text] [Related]

  • 10. Production and purification of an untagged recombinant pneumococcal surface protein A (PspA4Pro) with high-purity and low endotoxin content.
    Figueiredo DB, Carvalho E, Santos MP, Kraschowetz S, Zanardo RT, Campani G, Silva GG, Sargo CR, Horta ACL, de C Giordano R, Miyaji EN, Zangirolami TC, Cabrera-Crespo J, Gonçalves VM.
    Appl Microbiol Biotechnol; 2017 Mar 01; 101(6):2305-2317. PubMed ID: 27889801
    [Abstract] [Full Text] [Related]

  • 11. PspA-mediated aggregation protects Streptococcus pneumoniae against desiccation on fomites.
    Lane JR, Tata M, Yasmin R, Im H, Briles DE, Orihuela CJ.
    mBio; 2023 Dec 19; 14(6):e0263423. PubMed ID: 37982608
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Capsule does not block antibody binding to PspA, a surface virulence protein of Streptococcus pneumoniae.
    Daniels CC, Briles TC, Mirza S, Håkansson AP, Briles DE.
    Microb Pathog; 2006 May 19; 40(5):228-33. PubMed ID: 16540281
    [Abstract] [Full Text] [Related]

  • 14. Bactericidal effect of bovine lactoferrin and synthetic peptide lactoferrin chimera in Streptococcus pneumoniae and the decrease in luxS gene expression by lactoferrin.
    León-Sicairos N, Angulo-Zamudio UA, Vidal JE, López-Torres CA, Bolscher JG, Nazmi K, Reyes-Cortes R, Reyes-López M, de la Garza M, Canizalez-Román A.
    Biometals; 2014 Oct 19; 27(5):969-80. PubMed ID: 25053107
    [Abstract] [Full Text] [Related]

  • 15. Phase variable desialylation of host proteins that bind to Streptococcus pneumoniae in vivo and protect the airway.
    King SJ, Hippe KR, Gould JM, Bae D, Peterson S, Cline RT, Fasching C, Janoff EN, Weiser JN.
    Mol Microbiol; 2004 Oct 19; 54(1):159-71. PubMed ID: 15458413
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The conformation and function of a multimodular glycogen-degrading pneumococcal virulence factor.
    Lammerts van Bueren A, Ficko-Blean E, Pluvinage B, Hehemann JH, Higgins MA, Deng L, Ogunniyi AD, Stroeher UH, El Warry N, Burke RD, Czjzek M, Paton JC, Vocadlo DJ, Boraston AB.
    Structure; 2011 May 11; 19(5):640-51. PubMed ID: 21565699
    [Abstract] [Full Text] [Related]

  • 18. Enhanced protection against pneumococcal infection elicited by immunization with the combination of PspA, PspC, and ClpP.
    Cao J, Chen D, Xu W, Chen T, Xu S, Luo J, Zhao Q, Liu B, Wang D, Zhang X, Shan Y, Yin Y.
    Vaccine; 2007 Jun 28; 25(27):4996-5005. PubMed ID: 17524530
    [Abstract] [Full Text] [Related]

  • 19. DiiA is a novel dimorphic cell wall protein of Streptococcus pneumoniae involved in invasive disease.
    Escolano-Martínez MS, Domenech A, Yuste J, Cercenado MI, Ardanuy C, Liñares J, de la Campa AG, Martin-Galiano AJ.
    J Infect; 2016 Jul 28; 73(1):71-81. PubMed ID: 27105656
    [Abstract] [Full Text] [Related]

  • 20. Pneumococcal surface protein A (PspA) is effective at eliciting T cell-mediated responses during invasive pneumococcal disease in adults.
    Baril L, Dietemann J, Essevaz-Roulet M, Béniguel L, Coan P, Briles DE, Guy B, Cozon G.
    Clin Exp Immunol; 2006 Aug 28; 145(2):277-86. PubMed ID: 16879247
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.